Plenvu

Active Ingredient(s): Polyethylene Glycol 3350 + Sodium Ascorbate + Sodium Sulfate + Ascorbic Acid + Sodium Chloride + Potassium Chloride
FDA Approved: * May 4, 2018
Pharm Company: * NORTHSTAR HLTHCARE
Category: Laxative

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Plenvu Overview

Polyethylene glycol (PEG; /pliθlin lakl, -kl/) is a polyether compound with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH.[3] Contents 1 Uses 1.1 Medical uses 1.2 Chemical uses 1.3 Biological uses 1.4 Commercial uses 1.5 Industrial uses 1.6 Recreational uses 2...

Read more Plenvu Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Polyethylene_glycol

Recent Plenvu Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Polyethylene Glycol 3350 + Sodium Ascorbate + Sodium Sulfate + Ascorbic Acid + Sodium Chloride + Potassium Chloride
  • For Solution: 7.54gm + 140gm + 2.2gm + 48.11gm + 5.2gm + 9gm
  • Solution: 140g + 48.11g + 9g + 7.54g + 5.2g + 2.2g
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Plenvu: (1 result)

Sorted by National Drug Code
  • 65649-400 Plenvu Kit by Salix Pharmaceuticals, Inc

Drugs with one or more similar ingredients: (34 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA